Kerri Kaplan, President and CEO of the Lustgarten Foundation, the world’s largest private funder of pancreatic cancer research. Under her leadership, Lustgarten has helped drive major breakthroughs — from the first FDA-approved immunotherapy for pancreatic cancer to advances in early detection and personalized treatment that offer new hope to patients and families. Kerri also shares how the Foundation began, the meaning behind its name, and how collaborations like Stand Up To Cancer are accelerating progress in prevention, treatment, and survivorship.